Table 2.
Fitted Multinomial Logit Model |
||
---|---|---|
M1: Main effect of Active MMP-2 | M2: Main effect of Active MMP-2, controlling for the main effects of Pro-MMP-9 & Pro-MMP-2 | |
Adenoma (A) vs. Normal (N): | ||
Intercept | −1.315*** (0.329) | −1.149** (0.504) |
Active MMP-2 | 0.037** (0.012) | 0.050** (0.017) |
Pro-MMP-2 | −0.005 (0.003) | |
Pro-MMP-9 | 0.001 (0.001) | |
High Grade Dysplasia(HGD) vs. Normal (N): | ||
Intercept | −2.798*** (0.628) | −2.046** (0.716) |
Active MMP-2 | 0.066*** (0.017) | 0.095*** (0.030) |
Pro-MMP-2 | −0.013 (0.008) | |
Pro-MMP-9 | 0.001 (0.001) | |
Cancer (C) vs. Normal (N): | ||
Intercept | −4.494*** (1.196) | −3.606** (1.316) |
Active MMP-2 | 0.084*** (0.021) | 0.114*** (0.033) |
Pro-MMP-2 | −0.014 (0.008) | |
Pro-MMP-9 | 0.001 (0.001) | |
−2LL | 154.18 | 144.70 |
Pseudo-R2 Statistic | 0.269 | 0.314 |
p<.05;
p<.01;
p<.001;
tissue samples, n=79, patients, n=30